Loading...

RVMD REVOLUTION MEDICINES INC Expansion Plans 8-K Filing

RVLT

RVMD

REVOLUTION MEDICINES INC

(RVMD)

2025 8-K

Show Summary

Show Summary

Strategic Alliances

Financial Statements

Financial Results

Pipeline Updates

Financial Results

Clinical Trial Update

Pipeline Update

Financial Results and Board...

Pipeline Updates and Financ...

Annual Meeting of Stockholders

Financial Results Announcement

Financial Results Announcement

Amendment to 8-K

Acquisition of EQRx, Inc.

Financial Results Announcement

Merger of Equals

Pipeline Updates

Pipeline Updates

Financial Results Announcement

Merger Agreement

Annual Meeting of Stockholders

Financial Results Announcement

Underwriting Agreement

Financial Results Announcement

Results of Operations and F...

External Links:

On June 23, 2025, Revolution Medicines, Inc. entered into a $250 million Royalty Purchase Agreement with Royalty Pharma and a $750 million loan agreement for funding its drug development, impacting future royalty payments based on product sales.

AI Assistant

REVOLUTION MEDICINES INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.